
Kleefstra Syndrome: Unveiling the Genetic Mysteries Behind a Point Mutation
Uncover the impact of genetic testing on Kleefstra syndrome, focusing on early diagnosis, personalized treatment plans, and informed family planning strategies.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Uncover the impact of genetic testing on Kleefstra syndrome, focusing on early diagnosis, personalized treatment plans, and informed family planning strategies.

Explore how genetic testing uncovers L1 syndrome's mysteries, guiding diagnosis, treatment, family planning, and advancing research for personalized medicine.

Explore lamellar ichthyosis management with genetic testing. Unlock early diagnosis, personalized treatment, and family planning insights for this rare skin disorder.

Unlock precision care for Lennox-Gastaut Syndrome with genetic testing. Discover targeted treatments, improved outcomes, and personalized management strategies.

Explore how genetic testing aids in early diagnosis, family planning, and research for Lethal Congenital Contracture Syndrome, unlocking better care options.

Explore genetic testing for Limb-Girdle Muscular Dystrophy (LGMD) to understand mutations, enable early diagnosis, inform family planning, and guide treatment.

Unlock the potential of genetic testing to accurately diagnose lymphoproliferative disorders, uncover genetic mutations, and guide personalized treatment options.

Explore how genetic testing uncovers key mutations causing malignant migrating partial seizures in infants, aiding in diagnosis, treatment, and family planning.